ROSEN TERRY J — SEC Form 4 filings
SEC reporting owner CIK 1182473. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-25 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 19,800 shares, $201,465 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 54,691 shares, $1,203,959 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 28,947 shares @ $21.88 ($633,485) in Arcus Biosciences, Inc., filed 2025-12-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | Chief Executive Officer, Director | 9 | 1 leg · 19,800 sh · $201,465 | 2 legs · 54,691 sh · $1,203,959 | 10 |
| IDEAYA Biosciences, Inc. (IDYA) | Director | 3 | — | — | 3 |
Form 4 filings — ROSEN TERRY J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 79,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Arcus Biosciences, Inc. (RCUS) | Gift (G): 35,000 @ $0 | EDGAR |
| 2026-01-02 | 4 | Arcus Biosciences, Inc. (RCUS) | Gift (G): 2,400 @ $0 | EDGAR |
| 2025-12-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 28,947 @ $21.88 · Sale (S): 25,744 @ $22.16 | EDGAR |
| 2025-06-26 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Purchase (P): 19,800 @ $10.18 | EDGAR |
| 2025-01-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 165,000 @ $0 · Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 37,882 @ $16.08 | EDGAR |
| 2024-06-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 12,670 @ $16.97 | EDGAR |
| 2024-05-31 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 16,200 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 100,000 @ $0 · Grant/award (A): 405,900 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1182473 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →